HomeInvestors HealthAstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy... AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition (AZN:NASDAQ) By BOMAR ENT. March 17, 2025 FacebookTwitterPinterestWhatsApp Roland Magnusson EsoBiotec SA has entered into a definitive agreement to be acquired by AstraZeneca (NASDAQ:AZN) for up to $1 billion, on a cash and debt-free basis, it said on Monday. The deal includes an initial payment of $425 million on closing, and up Source link Previous articleBeating the StreetNext articleKnit Socks!: 17 Classic Patterns for Cozy Feet latest articles explore more Nvidia Regains Steam as It Enters the Enterprise AI Agent Race – March 11, 2026 Crypto Technical Analysis for Beginners: Master Moving Averages, VWAP, and Price Action to Trade with Confidence He Made $65,000/Month on His First Rental Arbitrage “Contract” (Real Numbers!) Time Series Analysis in Trading: Market Secrets $SPY High Probability Trading Strategies Muslim Mob Halts Church Roof Repairs in Indonesia LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
